Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

NTHI

STRONG SELL

NeOnc Technologies Holdings, Inc. · Healthcare · United States · $89M · Avg Vol: $371K/d

1
StockRank
Get insider-trade alerts
Q
13
V
23
M
21
P/E (TTM)
—
ROE
—
D/E
—
Dividend %
—
Dir. Trades · 180d
+$326.9K →
Buybacks · 180d
None →

COMPANY DESCRIPTION

NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for difficult-to-treat cancers, particularly brain tumors, using proprietary nanotechnology and drug delivery systems. The company's unique approach aims to overcome the blood-brain barrier, allowing for targeted drug delivery to enhance efficacy and reduce systemic toxicity. NeOnc seeks to address significant unmet medical needs in oncology.

FINANCIAL SUMMARY (USD)

Year20212022202320242025CAGRTTM
Revenue020.0K70.5K83.0K40.0K26.0%—
EPS-0.18-0.16-0.80-0.63-3.20—-1.71
Shares18.7M18.7M18.7M18.7M21.7M+15.7%25.9M
Debt1.1M50.0K6.6M24.7K6.3M53.1%0.3M
Equity-2.6M-1.6M-14.0M-5.5M-17.5M——
Op CF-0.4M-0.9M-1.9M-4.2M-20.4M—-21.7M
Inv CF———0-0.5M——
Fin CF0.3M1.5M1.3M4.2M20.9M——
Loading 1Y...
PRICE (1Y)-27.6%
3.253.754.264.765.27Jun 12Jul 7Jul 27
SMA 50SMA 200
Close
$3.44
RSI (14)
31.3
52W High
$12.99
From 52W High
0.3%

SCORE BREAKDOWN

Quality
13
ROIC (ROA)
-354.6%*0.9
ROE
—N/A
GP/Assets
0.0%10.1
Op. Margin
0.0%41.3
FCF/Assets
-738.9%0.1
Piotroski
12.3
Int. Cover
-11.2x22.5
D/E Ratio
—N/A
Current Ratio
0.13x0.5
Value
23
P/E (TTM)
—N/A
EV/EBITDA
—N/A
P/FCF
—N/A
P/B
-6.0x25.0
P/S
—0.3
Div Yield
—N/A
Momentum
21
52W High %
26%6.2
RS 6M
-69%5.7
SMA 50/200
0.61x3.8
EPS Rev 4W
0.0%62.6
EPS Rev 12W
-42.1%3.2
EPS Improve
+56%58.0
Q Growth
—N/A

FUNDAMENTALS

Market Cap
$89M
P/E (Forward)
-4.3x
Gross Margin
—

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of NTHI are excluded.

TickerCompanyMkt CapStockRankSignal
NTHINeOnc Technologies Holdings, Inc.(you)$89M1STRONG SELL
INOInovio Pharmaceuticals, Inc.$80M0STRONG SELL
ALDXAldeyra Therapeutics, Inc.$92M4STRONG SELL
ELTXElicio Therapeutics, Inc.$79M3STRONG SELL
EXOZeXoZymes, Inc.$73M0STRONG SELL
2592.HKCloudbreak Pharma Inc.$110M1STRONG SELL
ONCYOncolytics Biotech Inc.$97M5STRONG SELL
RNTXRein Therapeutics Inc.$68M2STRONG SELL
2257.HKSirnaomics Ltd.$64M1STRONG SELL
RANIRani Therapeutics Holdings, Inc.$117M2STRONG SELL

Peer medians: ROE -25.6% · P/E 27.6x · Gross margin 50.5%

NeOnc Technologies Holdings, Inc. (NTHI) — Stock Score Summary

NeOnc Technologies Holdings, Inc. (NTHI) has a MoatMap StockRank of 1/100 based on Quality (13/100), Value (23/100), and Momentum (21/100) factor scores. The current signal is STRONG SELL.

NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for difficult-to-treat cancers, particularly brain tumors, using proprietary nanotechnology and drug delivery systems. The company's unique approach aims to overcome the blood-brain barrier, allowing for targeted drug delivery to enhance efficacy and reduce systemic toxicity. NeOnc seeks to address significant unmet medical needs in oncology.

Key Financial Metrics

Price$3.44
Market Cap$89M
P/E (Forward)-4.34
Price/Book-5.97
Operating Margin0.0%
Free Cash Flow$-21M

NeOnc Technologies Holdings, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is NeOnc Technologies Holdings, Inc.’s (NTHI) StockRank?
MoatMap’s StockRank for NeOnc Technologies Holdings, Inc. (NTHI) is 1/100, with a Strong Sell signal. It is a composite of Quality (13), Value (23), and Momentum (21) factor ranks across MoatMap’s 20,000+ stock universe.
Does NeOnc Technologies Holdings, Inc. have an economic moat?
NeOnc Technologies Holdings, Inc. (NTHI) has a Quality factor score of 13/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is NeOnc Technologies Holdings, Inc. a buy, hold, or sell?
MoatMap’s current signal for NeOnc Technologies Holdings, Inc. (NTHI) is Strong Sell, based on a StockRank of 1/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is NeOnc Technologies Holdings, Inc. in?
NeOnc Technologies Holdings, Inc. (NTHI) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksNTHI deep dive reportAI ChampionsHow we score stocksSense-check another stock